卵巢恶性肿瘤的发病率仅次于子宫颈癌,但其死亡率占妇科恶性肿瘤首位。主要由于病因不明,缺乏早期诊断方法,治疗的规律尚未完全掌握。因此,在过去的30年间,临床治疗工作无重大突破,生存率徘徊不前,一般五年生存率仅15～25％。为了进一步改善卵巢恶性肿瘤的治疗效果,国外许多学者作了不懈地努力。兹扼要作一介绍。 The incidence of ovarian cancer is second only to cervical cancer, but the mortality rate of gynecologic malignancies in the first place. Mainly due to unknown etiology, the lack of early diagnosis, treatment of the law has not yet fully mastered. Therefore, in the past 30 years, there has been no major breakthrough in clinical treatment and the survival rate has stagnated. The general five-year survival rate is only 15 to 25%. In order to further improve the therapeutic effect of ovarian cancer, many foreign scholars have made unremitting efforts. Here is a brief introduction.